G70.00G70.01

Myasthenia Gravis

Autoimmune neuromuscular disorder causing fluctuating muscle weakness from acetylcholine receptor antibody attack.

PtosisDiplopiaDysphagiaFatigable limb weaknessRespiratory muscle weakness

Key Documentation Elements

  • MGFA classification (I-V) and quantitative MG score
  • Antibody status (AChR-Ab, MuSK-Ab, seronegative)
  • Current immunotherapy (pyridostigmine, prednisone, azathioprine, rituximab)
  • Respiratory function (FVC, NIF) monitoring
  • Thymectomy status and thymic pathology

Documentation Challenges

  • Documenting MGFA clinical classification and quantitative MG score
  • Recording antibody status (AChR, MuSK, LRP4)
  • Capturing crisis triggers and respiratory function monitoring
  • Tracking immunotherapy regimen and response

Billing Considerations

  • G70.00 (without exacerbation) vs G70.01 (in exacerbation/crisis)
  • HCC implications for autoimmune neurological conditions
  • Plasma exchange and IVIG infusion procedure coding

Frequently Asked Questions

What distinguishes G70.00 from G70.01?

G70.00 is MG without acute exacerbation, while G70.01 is MG in exacerbation or crisis. Scribeable selects based on your documented symptom status and respiratory function, ensuring accurate acuity coding.

How does Scribeable document MG management?

Scribeable captures MGFA classification, antibody results, medication regimens, respiratory monitoring, and crisis management from your encounter, creating structured neuromuscular disorder documentation.

Automate MG Documentation

Scribeable captures all required elements for MG from your patient conversation. AI-assisted ICD-10 coding and HCC capture.

ICD-10 Codes

G70.00G70.01

Myasthenia Gravis Documentation Guide

Autoimmune neuromuscular disorder causing fluctuating muscle weakness from acetylcholine receptor antibody attack.

ICD-10 Codes: G70.00, G70.01

Common Symptoms

  • Ptosis
  • Diplopia
  • Dysphagia
  • Fatigable limb weakness
  • Respiratory muscle weakness

Key Documentation Elements

  • MGFA classification (I-V) and quantitative MG score
  • Antibody status (AChR-Ab, MuSK-Ab, seronegative)
  • Current immunotherapy (pyridostigmine, prednisone, azathioprine, rituximab)
  • Respiratory function (FVC, NIF) monitoring
  • Thymectomy status and thymic pathology

Documentation Challenges

  • Documenting MGFA clinical classification and quantitative MG score
  • Recording antibody status (AChR, MuSK, LRP4)
  • Capturing crisis triggers and respiratory function monitoring
  • Tracking immunotherapy regimen and response

Billing Considerations

  • G70.00 (without exacerbation) vs G70.01 (in exacerbation/crisis)
  • HCC implications for autoimmune neurological conditions
  • Plasma exchange and IVIG infusion procedure coding

Frequently Asked Questions

What distinguishes G70.00 from G70.01?

G70.00 is MG without acute exacerbation, while G70.01 is MG in exacerbation or crisis. Scribeable selects based on your documented symptom status and respiratory function, ensuring accurate acuity coding.

How does Scribeable document MG management?

Scribeable captures MGFA classification, antibody results, medication regimens, respiratory monitoring, and crisis management from your encounter, creating structured neuromuscular disorder documentation.

Related Conditions